Silo Wellness Inc.

SILO

CA8271242072

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 20:44:08 28/08/2023 BST			5-day change	1st Jan Change
0.01 ^CAD	+100.00%		-.--%	-.--%

2023	Silo Wellness Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	CI
2023	Silo Wellness Inc. announced that it expects to receive CAD 2 million in funding	CI

Silo Wellness Inc Announces Demise of Maurice ‘Moe’ Colson, Board Member

April 08, 2021 at 12:11 am

Silo Wellness Inc. announced the passing of board member, Maurice ‘Moe’ Colson, who passed away on March 26, 2021.

Latest news about Silo Wellness Inc.

Silo Wellness Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	29/09/23	CI
Silo Wellness Inc. announced that it expects to receive CAD 2 million in funding	28/08/23	CI
Silo Wellness Inc. enter into a letter of intent to acquire NUGL Inc. for CAD 40.2 million.	28/08/23	CI
Kaya Group Forges Partnership with Silo Wellness for Psychedelic Wellness Experiences and Retreats	03/08/23	CI
Silo Wellness Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	28/06/23	CI
Silo Wellness Inc. Auditor Raises 'Going Concern' Doubt	04/04/23	CI
Silo Wellness Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023	04/04/23	CI
Silo Wellness Inc. Reports Earnings Results for the Full Year Ended October 31, 2022	04/04/23	CI
Michael Hartman entered into a definitive stock purchase agreement to acquire SW Holdings, Inc. from Silo Wellness Inc. for CAD 0.21 million.	27/03/23	CI
Silo Wellness Inc. Announces Resignation of Gerard Lee from as A Director of the Board	17/02/23	CI
Silo Wellness Inc. Executes Binding Term Sheet for A Joint Venture with New Frontier Ranch	20/10/22	CI
Silo Wellness Inc. completed the acquisition of Dyscovry Science Ltd.	16/10/22	CI
Silo Wellness Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022	28/09/22	CI
384,082 Common Shares of Yukoterre Resources Inc. are subject to a Lock-Up Agreement Ending on 24-SEP-2022.	23/09/22	CI
Silo Wellness Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2022	30/06/22	CI
Silo Wellness Inc. Announces Change of Chief Executive Officer	09/06/22	CI
Silo Wellness Inc. executed a nonbinding letter of intent to acquire Dyscovry Science Ltd.	30/05/22	CI
Silo Wellness Inc. announced that it expects to receive CAD 5.95 million in funding from Alpha Blue Ocean Investment Group	13/04/22	CI
Silo Wellness Inc. Reports Earnings Results for the First Quarter Ended January 31, 2022	30/03/22	CI
384,081 Common Shares of Yukoterre Resources Inc. are subject to a Lock-Up Agreement Ending on 24-MAR-2022.	23/03/22	CI
Silo Wellness Inc. Reports Earnings Results for the Full Year Ended October 31, 2021	02/03/22	CI
Silo Wellness Inc. Auditor Raises 'Going Concern' Doubt	01/03/22	CI
Silo Wellness Inc. announced that it expects to receive $0.494988 million in funding from Orthogonal Thinker, Inc., Investment Arm	02/02/22	CI
Silo Wellness Signs Distribution Deal with Flawless CBD for Functional Mushroom Products	02/02/22	CI
Silo Wellness Inc. Announces Board Changes	06/01/22	CI

Silo Wellness, Inc. is a Canada-based global psychedelics company. The Company is engaged in psilocybin wellness retreats. The Company operates through the Jamaica retreats segment. The Company offers psychedelic wellness retreats in Jamaica and is focused on doing the same in Oregon, United States. The Company also maintains rights in intellectual property (IP). In addition to its IP portfolio, The Company is focusing on consumer product and wellness retreat brand development for psychedelics. It is focusing on improving health and wellness by developing and introducing psychedelic medicine to reduce trauma and increase performance, by destigmatizing the active compounds in psychedelics and innovating ease of administration and ingestion.

Sector

Pharmaceuticals

Calendar

25/09/2024 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
SILO WELLNESS INC.	-.--%	1.13M
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
NOVARTIS AG	+9.78%	210B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B